Recurrent intradialytic paroxysmal atrial fibrillation: Hypotheses on onset mechanisms based on clinical data and computational analysis

Europace

Volumn 16, Issue 3, 2014, Pages 396-404

  Vincenti, Antonio ^a   Passini, Elisa ^b   Fabbrini, Paolo ^a   Luise, Maria Carmen ^c   Severi, Stefano ^b   Genovesi, Simonetta ^a,c  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Atrial fibrillation; Computational modelling; Electrolytes; Haemodialysis; P wave

Indexed keywords

ACETYLCHOLINE;

AGED; CASE REPORT; CLINICAL STUDY; ELECTROLYTE BLOOD LEVEL; END STAGE RENAL DISEASE; FEMALE; HEART ELECTROPHYSIOLOGY; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART RATE VARIABILITY; HEART VENTRICLE EXTRASYSTOLE; HEMODIALYSIS; HOLTER MONITORING; HUMAN; PAROXYSMAL HEART ATRIUM FIBRILLATION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SIMULATION; SYMPATHETIC TONE; VAGUS NERVE STIMULATION;

ATRIAL FIBRILLATION; COMPUTATIONAL MODELLING; ELECTROLYTES; HAEMODIALYSIS; P-WAVE;

ACTION POTENTIALS; ANIMALS; ATRIAL FIBRILLATION; COMPUTER SIMULATION; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MODELS, CARDIOVASCULAR; MYOCYTES, CARDIAC;

EID: 84895757435     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut346     Document Type: Review

References (74)

1. Zimmerman D, Sood MM, Rigatto C, Holden RM, Hiremath S, Clase CM. Systematic reviewand meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrol Dial Transplant 2012;27:3816-22.
2. Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol 2011;22:349-57.
3. Genovesi S, Pogliani D, Faini A, Valsecchi MG, Riva A, Stefani F et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 2005;46:897-902.
4. Genovesi S, Vincenti A, Rossi E, Pogliani D, Acquistapace I, Stella A et al. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis 2008;51:255-62.
5. Stafford P, Denbigh P, Vincent R. Frequency analysis of the P wave: comparative techniques. Pacing Clin Electrophysiol 1995;18:261-70.
6. Malik M, Bigger JT, Camm AJ, Breithardt G, Cerutti S, Cohen RJ et al. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996;17:354-81.
7. Courtemanche M, Ramirez RJ, Nattel S. Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model. Am J Physiol 1998; 275:H301-21.
8. Severi S, Corsi C, Cerbai E. From in vivo plasma composition to in vitro cardiac electrophysiology and in silico virtual heart: the extracellular calcium enigma. Philos Trans A, Math Phys Eng Sci 2009;367:2203-23.
9. Severi S, Grandi E, Pes C, Badiali F, Grandi F, Santoro A. Calcium and potassium changes during haemodialysis alter ventricular repolarization duration: in vivo and in silico analysis. Nephrol Dial Transplant 2008;23:1378-86.
10. Jacquemet V. Steady-state solutions in mathematical models of atrial cell electrophysiology and their stability. Math Biosci 2007;208:241-69.
11. 2+ model: sinus rhythm and chronic atrial fibrillation. Circ Res 2011; 109:1055-66.
12. Shampine LF, Reichelt MW. The MATLAB ODE suite. SIAM J Sci Comput 1997;18: 1-22.
13. Severi S, Pogliani D, Fantini G, Fabbrini P, Viganò MR, Galbiati E et al. Alterations of atrial electrophysiology induced by electrolyte variations: combined computational and P-wave analysis. Europace 2010;12:842-9.
14. Workman AJ, Kane KA, Rankin AC. The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation. Cardiovasc Res 2001;52:226-35.
15. Downar E, Janse MJ, Durrer D. The effect of 'ischemic' blood on transmembrane potentials of normal porcine ventricular myocardium. Circulation 1977;55:455-62.
16. Remppis A, Ritz E. Cardiac problems in the dialysis patient: beyond coronary disease. Semin Dial 2008;21:319-25.
17. Mall G, Huther W, Schneider J, Lundin P, Ritz E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant 1990;5:39-44.
18. Siedlecki AM, Jin X, Muslin AJ. Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure. Kidney Int 2009;75:800-8.
19. Gross ML, Ritz E. Non-coronary heart disease in dialysis patients: hypertrophy and fibrosis in the cardiomyopathy of uremia-beyond coronary heart disease. Semin Dial 2008;21:308-18.
20. Glassock RJ, Pecoits-Filho R, Barberato SH. Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 2009;4:S79-91.
21. Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C. Left atrial volume in end-stage renal disease: a prospective cohort study. J Hypertens 2006; 24:1173-80.
22. Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C. Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study. J Am Soc Nephrol 2007;18:1316-22.
23. Atar I, Konas D, Açikel S, Külah E, Atar A, Bozbaş H et al. Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol 2006;106: 47-51.
24. Daugirdas JT, Blake PG, Ing TS. Handbook of Dialysis. Boston: Lippincott Williams & Wilkins, 2007.
25. Dorbala S, Steinberg JS. Signal averaging of the P wave. In Zareba W, Maison-Blanche P, Locati EH (eds). Noninvasive Electrocardiology in Clinical Practice. Armonk: Futura Publishing Company, 2001. pp. 31-48.
26. Abe Y, Fukunami M, Yamada T, Ohmori M, Shimonagata T, Kumagai K et al. Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal-averaged electrocardiography: a prospective study. Circulation 1997; 96:2612-6.
27. Steinberg JS, Zelenkofske S, Wong SC, Gelernt M, Sciacca R, Menchavez E. Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation 1993;88:2618-22.
28. Hayashida N, Shojima T, Yokokura Y, Hori H, Yoshikawa K, Tomoeda H, et al. P-wave signal-averaged electrocardiogram for predicting atrial arrhythmia after cardiac surgery. Ann Thorac Surg 2005;79:859-64.
29. Cicek D, Camsari A, Pekdemir H, Kiykim A, Akkuş N, Sezer K, et al. Predictive value of P-wave signal-averaged electrocardiogram for atrial fibrillation in acute myocardial infarction. Ann Noninvasive Electrocardiol 2003;8:233-7.
30. Stafford PJ, Kamalvand K, Tan K, Vincent R, Sulke N. Prediction of maintenance of sinus rhythm after cardioversion of atrial fibrillation by analysis of serial signal-averaged P waves. Pacing Clin Electrophysiol 1998;21:1387-95.
31. Yamada T, Fukunami M, Shimonagata T, Kumagai K, Sanada S, Ogita H et al. Dispersion of signal-averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation. Eur Heart J 1999;20:211-20.
32. Szabo Z, Kakuk G, Fulop T, Mátyus J, Balla J, Kárpá ti I et al. Effects of haemodialysis on maximum P wave duration and P wave dispersion. Nephrol Dial Transplant 2002;17: 1634-8.
33. Tezcan UK, Amasyali B, Can I, Aytemir K, Köse S, Yavuz I et al. Increased P wave dispersion andmaximum Pwave duration after hemodialysis. Ann Noninvasive Electrocardiol 2004;9:34-8.
34. Ozcan T, Horoz M, Genctoy G, Uyar B, Camsari A, Kiykim AA. The influence of hemodialysis on P-wave signal-averaged electrocardiogram findings. Artif Organs 2007;31:612-6.
35. Jaroszynski AJ, Glowniak A, Sodolski T, Zaluska W, Widomska-Czekajska T, Ksiazek A. Effect of haemodialysis on signal-averaged electrocardiogram P-wave parameters. Nephrol Dial Transplant 2006;21:425-30.
36. Drighil A, Madias JE, Yazidi A, Bennani M, Bennis A, Ramdan B et al. P-wave and QRS complex measurements in patients undergoing hemodialysis. J Electrocardiol 2008; 41:60.
37. Ozben B, Toprak A, Koc M, Sumerkan M, Tanrikulu AM, Papila-Topal N, et al. P wave dispersion increases during hemodialysis sessions. Nephron Clin Pract 2009;112: c171-6.
38. Shimada K, Tomita T, Kamijo Y, Higuchi M, Ito K, Koizumi Y et al. Hemodialysis-induced P-wave signal-averaged electrocardiogram alterations are indicative of vulnerability to atrial arrhythmias. Circ J 2012;76:612-7.
39. Madias JE. Pwaves in patients with changing edematous states. Pacing Clin Electrophysiol 2004;27:749-56.
40. Madias JE. Increases in P-wave duration and dispersion after hemodialysis are totally (or partially) due to the procedure-induced alleviation of the body fluid overload: a hypothesis with strong experimental support. Ann Noninvasive Electrocardiol 2005;10: 129-33.
41. Fabbrini P, Sironi E, Pieruzzi F, Galbiati E, Viganò MR, Stella A et al. P wave duration, atrial dimension and atrial fibrillation in hemodialysis patients. Nephrol Dial Transplant 2012;27(S2):244.
42. Hainsworth R. Reflexes from the heart. Physiol Rev 1991;71:617-58.
43. Palmer BF, Henrich WL. Recent advances in the prevention and management of intradialytic hypotension. J Am Soc Nephrol 2008;19:8-11.
44. Barnas MGW, Boer WH, Koomans HA. Hemodynamic patterns and spectral analysis of heart rate variability during dialysis hypotension. J Am Soc Nephrol 1999;10: 2577-84.
45. Genovesi S, Rivera R, Fabbrini P, Dossi C, Bonforte G, Mircoli L et al. Dynamic QT interval analysis in uraemic patients receiving chronic haemodialysis. J Hypertens 2003;21:1921-6.
46. Genovesi S, Bracchi O, Fabbrini P, Luisetto E, Viganò MR, Lucini D, et al. Differences in heart rate variability during haemodialysis and haemofiltration. Nephrol Dial Transplant 2007;22:2256-62.
47. Cavalcanti S, Severi S, Chiari L, Avanzolini G, Enzmann G, Bianco G, et al. Autonomic nervous function during haemodialysis assessed by spectral analysis of heart-rate variability. Clin Sci (Lond) 1997;92:351-9.
48. Rubinger D, Backenroth R, Sapoznikov D. Sympathetic activation and baroreflex function during intradialytic hypertensive episodes. PLoS ONE 2012;7:e36943.
49. Rubinger D, Revis N, Pollak A, Luria MH, Sapoznikov D. Predictors ofhaemodynamic instability and heart rate variability during haemodialysis. Nephrol Dial Transplant 2004;19:2053-60.
50. Kingwell BA, Thompson JM, Kaye DM, Mcpherson GA, Jennings GL, Esler MD. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 1994;90:234-40.
51. Houle MS, Billman GE. Low-frequency component of the heart rate variability spectrum: a poor marker of sympathetic activity. Am J Physiol 1999;276:H215-23.
52. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986;59:178-93.
53. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991;84:482-92.
54. Mark AL. The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol 1983;1:90-102.
55. Gruppo Emodialisi e Patologie Cardiovascolari. Multicentre, cross-sectional study of ventricular arrhythmias in chronically haemodialysed patients. Lancet 1988;2:305-9.
56. Abe S, Yoshizawa M, Nakanishi N, Yazawa T, Yokota K, Honda M et al. Electrocardiographic abnormalities in patients receiving hemodialysis. Am Heart J 1996;131: 1137-44.
57. Santoro A, Mancini E, London G, Mercadal L, Fessy H, Perrone B et al. Patients with complex arrhythmias during and after haemodialysis suffer from different regimens of potassium removal. Nephrol Dial Transplant 2008;23:1415-21.
58. Genovesi S, Dossi C, Vigano MR, Galbiati E, Prolo F, Stella A et al. Electrolyte concentration during haemodialysis and QT interval prolongation in uraemic patients. Europace 2008;10:771-7.
59. Lewis T, Rury AN, Bulger HA. Observation upon atrial flutter and fibrillation. VI. Refractory period and rate of propagation in the auricle: their relation to block in the auricular walls and to flutter etc. Heart 1921;8:84-134.
60. Hoff HE, Geddes LA. Cholinergic factor in atrial fibrillation. J Appl Physiol 1955;8: 177-92.
61. Randall WC. Changing perspectives concerning neural control of the heart. In Armour JA, Ardell JL (eds). Neurocardiology. New York: Oxford University Press, 1994.
62. Armour JA, Murphy DA, Yuan BX, Macdonald S, Hopkins DA. Gross and microscopic anatomy of the human intrinsic cardiac nervous system. Anat Rec 1997;247: 289-98.
63. Scherlag BJ, Yamanashi W, Patel U, Lazzara R, Jackman WM. Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation. J Am Coll Cardiol 2005; 45:1878-86.
64. Zhou J, Scherlag BJ, Edwards J, Jackman WM, Lazzara R, Po SS. Gradients of atrial refractoriness and inducibility of atrial fibrillation due to stimulation of ganglionated plexi. J Cardiovasc Electrophysiol 2007;18:83-90.
65. Sharifov OF, Fedorov VV, Beloshapko GG, Glukhov AV, Yushmanova AV, Rosenshtraukh LV. Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs. J Am Coll Cardiol 2004;43:483-90.
66. Po SS, Scherlag BJ, Yamanashi WS, Edwards J, Zhou J, Wu R, et al. Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions. Heart Rhythm 2006;3:201-8.
67. Scherlag BJ, Hou YL, Lin J, Lu Z, Zacharias S, Dasari T et al. An acute model for atrial fibrillation arising from a peripheral atrial site: evidence for primary and secondary triggers. J Cardiovasc Electrophysiol 2008;19:519-27.
68. Hou Y, Scherlag BJ, Lin J, Zhang Y, Lu Z, Truong K et al. Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fibrillation. J Am Coll Cardiol 2007;50: 61-8.
69. Lemola K, Chartier D, Yeh YH, Dubuc M, Cartier R, Armour A et al. Pulmonary vein region ablation in experimental vagal atrial fibrillation: role of pulmonary veins versus autonomic ganglia. Circulation 2008;117:470-7.
70. Lu Z, Scherlag BJ, Lin J, Niu G, Fung KM, Zhao L et al. Atrial fibrillation begets atrial fibrillation: autonomic mechanism for atrial electrical remodeling induced by shortterm rapid atrial pacing. Circ Arrhythm Electrophysiol 2008;1:184-92.
71. Patterson E, Po SS, Scherlag BJ, Lazzara R. Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm 2005;2:624-31.
72. Lu Z, Scherlag BJ, Lin J, Yu L, Guo JH, Niu G, et al. Autonomic mechanism for initiation of rapid firing from atria and pulmonary veins: evidence by ablation of ganglionated plexi. Cardiovasc Res 2009;84:245-52.
73. Wijffels MC, Dorland R, Allessie MA. Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol. J Cardiovasc Electrophysiol 1999;10: 178-93.
74. Vincenti A, Brambilla R, Fumagalli MG, Merola R, Pedretti S. Onset mechanism of paroxysmal atrial fibrillation detected by ambulatory Holter monitoring. Europace 2006;8:204-10.